Related Experiment Videos
Tissue distribution of exaprolol in rat
European Journal of Drug Metabolism and Pharmacokinetics
|January 1, 1985
Summary
Exaprolol, a beta-blocker, showed transient high lung accumulation after intravenous administration in rats. Oral dosing resulted in lower tissue levels, with distribution varying by organ and administration route.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Drug Metabolism
Background:
- Beta-adrenoceptor blocking drugs are crucial in cardiovascular therapy.
- Understanding drug disposition is essential for optimizing therapeutic efficacy and safety.
Purpose of the Study:
- To investigate the organ disposition of exaprolol, a beta-adrenoceptor blocking drug, in rats.
- To compare exaprolol distribution following intravenous and oral administration.
Main Methods:
- Administration of radiolabeled 3H-exaprolol (intravenous and oral) to rats.
- Measurement of exaprolol concentrations in various organs (lungs, heart, kidneys, liver) and plasma over time.
- Calculation of tissue-to-plasma ratios to characterize drug distribution.
Main Results:
- Intravenous exaprolol exhibited transient, extremely high accumulation in the lungs (peak 7.7% dose/g at 30 min).
- Heart, kidneys, and liver showed consistent tissue-to-plasma ratios of approximately ten after IV administration.
- Oral exaprolol administration resulted in lower overall tissue levels compared to IV.
- Tissue-to-plasma ratios after oral dosing initially increased before reaching stable levels.
Conclusions:
- Exaprolol distribution is significantly influenced by the route of administration in rats.
- The lungs are a primary site of transient accumulation following intravenous exaprolol.
- Organ-specific disposition patterns, particularly the high lung uptake, are key pharmacokinetic features of exaprolol.